Rivasur due volte alla settimana 4

Rivasur due volte alla settimana 4 is a medicine authorised by Swissmedic under authorisation number 68897. The authorisation holder is Zambon Svizzera SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 February 2024 and the authorisation is limited until 12 February 2029. ATC code N06DA03 places the medicine in the group Psychoanaleptics.

  • Dispensing category B
  • Authorisation number 68897
  • ATC N06DA03
  • Synthetic medicines
Authorisation data
Authorisation number68897
NameRivasur due volte alla settimana 4
Full nameRivasur due volte alla settimana 4,6 mg/24 ore, cerotto transdermico
Authorisation holderZambon Svizzera SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN06DA03
First authorisation13 February 2024
Authorisation validity12 February 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Rivasur due volte alla settimana 4,6 mg/24 ore, cerotto transdermicoB13 February 2024
2Rivasur due volte alla settimana 9,5 mg/24 ore, cerotto transdermicoB13 February 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
28PflasterN06DA0301.99.0.B
316PflasterN06DA0301.99.0.B
68PflasterN06DA0301.99.0.B
716PflasterN06DA0301.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Rivasur due volte alla settimana 4 authorised in Switzerland?

Yes. Rivasur due volte alla settimana 4 is authorised by Swissmedic under authorisation number 68897, data as of 01 September 2026. The authorisation is limited until 12 February 2029.

Which dispensing category does Rivasur due volte alla settimana 4 have?

Rivasur due volte alla settimana 4 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Rivasur due volte alla settimana 4?

The authorisation holder is Zambon Svizzera SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com